SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Susan R. Davis, Roisin Worsley, Androgen treatment of postmenopausal women, The Journal of Steroid Biochemistry and Molecular Biology, 2014, 142, 107

    CrossRef

  2. 2
    Saskia Poels, Jos Bloemers, Kim van Rooij, Hans Koppeschaar, Berend Olivier, Adriaan Tuiten, Een vernieuwende farmacotherapeutische behandeling voor vrouwen met hypoactive sexual desire disorder, Neuropraxis, 2014, 18, 1, 32

    CrossRef

  3. 3
    Saskia Poels, Jos Bloemers, Kim van Rooij, Hans Koppeschaar, Berend Olivier, Adriaan Tuiten, Two novel combined drug treatments for women with hypoactive sexual desire disorder, Pharmacology Biochemistry and Behavior, 2014, 121, 71

    CrossRef

  4. 4
    S. R. Davis, Androgen therapy in women, beyond libido, Climacteric, 2013, 16, S1, 18

    CrossRef

  5. 5
    Vicki Osborne, Safety of testosterone therapy indicated for hypoactive sexual desire disorder in postmenopausal women, Adverse Drug Reaction Bulletin, 2013, 280, 1, 1079

    CrossRef

  6. 6
    Joanne Kotsopoulos, Steven A. Narod, Androgens and breast cancer, Steroids, 2012, 77, 1-2, 1

    CrossRef

  7. 7
    Dennis A Davey, Androgens in women before and after the menopause and post bilateral oophorectomy: clinical effects and indications for testosterone therapy, Women's Health, 2012, 8, 4, 437

    CrossRef

  8. 8
    Amy Finch, Gareth Evans, Steven A Narod, BRCAcarriers, prophylactic salpingo-oophorectomy and menopause: clinical management considerations and recommendations, Women's Health, 2012, 8, 5, 543

    CrossRef

  9. 9
    Susan R. Davis, Glenn D. Braunstein, Efficacy and Safety of Testosterone in the Management of Hypoactive Sexual Desire Disorder in Postmenopausal Women, The Journal of Sexual Medicine, 2012, 9, 4
  10. 10
    Sonia L. Davison, Hypoactive sexual desire disorder, Current Opinion in Obstetrics and Gynecology, 2012, 24, 4, 215

    CrossRef

  11. 11
    C. Brock Woodis, Amber N. McLendon, Andrew J. Muzyk, Testosterone Supplementation for Hypoactive Sexual Desire Disorder in Women, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2012, 32, 1
  12. 12
    Kate Maclaran, Nick Panay, The safety of postmenopausal testosterone therapy, Women's Health, 2012, 8, 3, 263

    CrossRef

  13. 13
    Sonia L. Davison, Susan R. Davis, Androgenic hormones and aging — The link with female sexual function, Hormones and Behavior, 2011, 59, 5, 745

    CrossRef

  14. 14
    Susan R Davis, Cardiovascular and cancer safety of testosterone in women, Current Opinion in Endocrinology, Diabetes and Obesity, 2011, 18, 3, 198

    CrossRef

  15. 15
    Susan R. Davis, Rory Wolfe, Helen Farrugia, Angeline Ferdinand, Robin J. Bell, Author Response, The Journal of Sexual Medicine, 2010, 7, 2pt2
  16. 16
    Abdulmaged M. Traish, Louis J. Gooren, Safety of Physiological Testosterone Therapy in Women: Lessons from Female-to-Male Transsexuals (FMT) Treated with Pharmacological Testosterone Therapy, The Journal of Sexual Medicine, 2010, 7, 11
  17. You have free access to this content17
    Susan R. Davis, Should women receive androgen replacement therapy, and if so, how?, Clinical Endocrinology, 2010, 72, 2
  18. 18
    Susan A. Hall, Andre B. Araujo, Varant Kupelian, Nancy N. Maserejian, Thomas G. Travison, Testosterone and Breast Cancer, The Journal of Sexual Medicine, 2010, 7, 2pt2
  19. 19
    Abdulmaged M. Traish, Katharina Fetten, Martin Miner, Michael L. Hansen, Andre Guay, Testosterone and risk of breast cancer: appraisal of existing evidence, Hormone Molecular Biology and Clinical Investigation, 2010, 2, 1

    CrossRef